Thursday, October 17, 2024

Research and development for new drugs and disease treatments can be lengthy and costly. Indication expansion can help broaden the...

Thursday, October 17, 2024

Some human studies may be unfeasible or unethical, making cross-species research critical for drug discovery and biomarker validation. Cross-species research...

QIAGEN Digital Insights Tuesday, January 30, 2024

Two expert-curated databases exclusively licensed through QIAGEN link sequence-level somatic mutation data to detailed molecular information about functional and clinical...

QIAGEN Digital Insights Wednesday, November 1, 2023

COSMIC, the Catalogue Of Somatic Mutations In Cancer, is the world's largest and most comprehensive resource for exploring the impact...

QIAGEN Digital Insights Friday, October 27, 2023

Here's the scenario - You're a passionate scientist in a leading pharmaceutical company hoping to uncover a transformative drug candidate....

Monday, August 14, 2023

Some human studies may be unfeasible or unethical, making cross-species research critical for drug discovery and biomarker validation. Cross-species research...

Wednesday, July 12, 2023

Research and development for new drugs and disease treatments can be lengthy and costly. Indication expansion can help broaden the...

QIAGEN Digital Insights Monday, April 25, 2022

You need biomedical relationships knowledge for innovative data- and analytics-driven drug discovery. Yet this knowledge is locked in thousands of...

Sample to Insight
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram
This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.